Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

bluebird bio Stock News

BLUENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

bluebird bio (BLUE) Forecast

News

Earnings bluebird bio (BLUE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest bluebird bio Stock News | NASDAQ:BLUE | Benzinga

Get the latest news on bluebird bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on bluebird bio performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 16, 2025

Carlyle Group and Bluebird Bio shares are tra...
Benzinga Newsdesk - Apr 16, 2025, 1:14PM
bluebird bio Announces That After Three Weeks...
Benzinga Newsdesk - Apr 16, 2025, 8:07AM
Carlyle, SK Capital Partners, And Beacon Pare...
Benzinga Newsdesk - Apr 16, 2025, 7:39AM

Friday, April 04, 2025

Deal Dispatch: US M&A Is Quiet, But Abroad? Volume Is Spiking
Anthony Noto - Apr 4, 2025, 3:07PM

Monday, March 31, 2025

BlueBird Shares Are Up Today: What's Going On?
Vaishali Prayag - Mar 31, 2025, 3:49PM
BlueBird Bio shares are trading higher after ...
Benzinga Newsdesk - Mar 31, 2025, 2:04PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Mar 31, 2025, 1:05PM
Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps
Vandana Singh - Mar 31, 2025, 11:24AM
Barclays Maintains Overweight on bluebird bio...
Benzinga Newsdesk - Mar 31, 2025, 10:43AM
Market-Moving News for March 31st
Benzinga Newsdesk - Mar 31, 2025, 7:51AM

Friday, March 28, 2025

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Mar 28, 2025, 5:05PM
Bluebird Bio shares are trading higher after ...
Benzinga Newsdesk - Mar 28, 2025, 4:19PM
bluebird bio Confirms Receipt Of An Unsolicit...
Benzinga Newsdesk - Mar 28, 2025, 4:16PM
'Bluebird Gets New M&A Bid, Seeking To Top Pr...
Benzinga Newsdesk - Mar 28, 2025, 3:56PM
Watching bluebird bio; Traders Circulate Unco...
Benzinga Newsdesk - Mar 28, 2025, 3:55PM

Tuesday, March 11, 2025

Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Vandana Singh - Mar 11, 2025, 10:17AM

Monday, February 24, 2025

JP Morgan Upgrades bluebird bio to Neutral
Benzinga Newsdesk - Feb 24, 2025, 7:00AM

Friday, February 21, 2025

Dow Tumbles Over 700 Points; US Services PMI Falls In February
Avi Kapoor - Feb 21, 2025, 2:17PM
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
Nabaparna Bhattacharya - Feb 21, 2025, 8:53AM
Bluebird Bio shares are trading lower. The co...
Benzinga Newsdesk - Feb 21, 2025, 8:14AM
Trading Halt: Halt status updated at 7:55:00 ...
Benzinga Newsdesk - Feb 21, 2025, 7:55AM
bluebird bio Agrees To Be Acquired By Carlyle...
Benzinga Newsdesk - Feb 21, 2025, 7:31AM
Trading Halt: Halted at 7:25:00 a.m. ET - Tra...
Benzinga Newsdesk - Feb 21, 2025, 7:25AM

Friday, December 13, 2024

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk - Dec 12, 2024, 7:50PM

Monday, December 09, 2024

Reported Sunday, bluebird bio Highlights 9-Ye...
Benzinga Newsdesk - Dec 9, 2024, 2:48AM

Saturday, December 07, 2024

bluebird bio Announced Long-Term Follow-Up Da...
Benzinga Newsdesk - Dec 7, 2024, 3:30PM

Thursday, December 05, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Dec 5, 2024, 4:05PM
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Dec 5, 2024, 6:01AM

Wednesday, December 04, 2024

bluebird bio Announces 1-for-20 Reverse Stock...
Benzinga Newsdesk - Dec 4, 2024, 4:06PM
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
Vandana Singh - Dec 4, 2024, 2:31PM
Bluebird Bio shares are trading higher after ...
Benzinga Newsdesk - Dec 4, 2024, 2:23PM
bluebird bio Joins CMMI Cell And Gene Therapy...
Benzinga Newsdesk - Dec 4, 2024, 8:49AM

Friday, November 29, 2024

FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
Vandana Singh - Nov 29, 2024, 8:07AM

Wednesday, November 27, 2024

bluebird bio shares are trading lower after t...
Benzinga Newsdesk - Nov 27, 2024, 1:50PM
FDA Investigating Serious Risk Of Hematologic...
Benzinga Newsdesk - Nov 27, 2024, 11:35AM

Friday, November 15, 2024

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
Vandana Singh - Nov 15, 2024, 2:05PM
RBC Capital Reiterates Sector Perform on blue...
Benzinga Newsdesk - Nov 15, 2024, 12:47PM
B of A Securities Downgrades bluebird bio to ...
Benzinga Newsdesk - Nov 15, 2024, 12:02PM
Barclays Maintains Overweight on bluebird bio...
Benzinga Newsdesk - Nov 15, 2024, 9:37AM

Thursday, November 14, 2024

bluebird bio Sees Q4 2024 Revenue At Least $2...
Benzinga Newsdesk - Nov 14, 2024, 7:03AM
bluebird bio Q3 2024 Adj EPS $(0.31) Beats $(...
Benzinga Newsdesk - Nov 14, 2024, 7:01AM
Earnings Scheduled For November 14, 2024
Benzinga Insights - Nov 14, 2024, 3:32AM

Wednesday, November 13, 2024

Exploring bluebird bio's Earnings Expectations
Benzinga Insights - Nov 13, 2024, 10:02AM

Tuesday, November 05, 2024

bluebird bio To Present Additional Long-Term ...
Benzinga Newsdesk - Nov 5, 2024, 9:19AM

Friday, October 11, 2024

Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
Vandana Singh - Oct 11, 2024, 9:09AM

Wednesday, September 25, 2024

The Analyst Verdict: bluebird bio In The Eyes Of 5 Experts
Benzinga Insights - Sep 25, 2024, 1:00PM
Wells Fargo Maintains Equal-Weight on bluebir...
Benzinga Newsdesk - Sep 25, 2024, 12:36PM

Tuesday, September 24, 2024

Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year
Vandana Singh - Sep 24, 2024, 12:14PM
Bluebird Bio Is Implementing A Restructuring ...
Benzinga Newsdesk - Sep 24, 2024, 7:06AM

Monday, September 23, 2024

Bluebird Bio shares are trading higher after ...
Benzinga Newsdesk - Sep 23, 2024, 4:11PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved